Sinensetin ameliorates osteoarthritis progression by modulating the NF-κB/NLRP3 signaling pathway and suppressing chondrocyte pyroptosis
European Journal of Histochemistry · 2026
DOI: 10.4081/ejh.2026.4587 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Histochemistry, 2026. Verfasst von Zhendong Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong. Hauptthemen laut MEDLINE: Pyroptosis, Chondrocytes, NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Sinensetin (SIN) is a natural flavonoid with potential anti‑inflammatory effects. This study investigated whether SIN ameliorates osteoarthritis (OA) and explored its underlying mechanisms. In vitro, SIN (0.05-1 μg/mL) protected human OA chondrocytes from IL‑1β‑induced viability loss. Transcriptome sequencing and molecular docking identified SERPINA3 as a candidate target of SIN. SIN reduced the expression of NLRP3, GSDMD, and ASC, inhibited pyroptotic morphology, decreased TUNEL‑positive cells and LDH release, and lowered IL‑1β and IL‑18 secretion in IL‑1β‑treated chondrocytes. Knockdown of SERPINA3 reversed these effects, suggesting that SIN acts through SERPINA3 to inhibit the NLRP3 inflammasome. In a rat DMM‑induced OA model, SIN (20 mg/kg/day for 6 weeks) alleviated pain, reduced OARSI scores, improved cartilage matrix staining (Safranin O, Masson's trichrome), attenuated synovial hyperplasia and posterior capsule adhesions, and decreased plasma IL‑1β and IL‑18 levels. Western blot of rat cartilage confirmed that SIN suppressed GSDMD and NLRP3 expression. These results indicate that SIN ameliorates OA progression by inhibiting SERPINA3‑mediated NF‑κB/NLRP3‑driven chondrocyte pyroptosis. SIN may be a potential therapeutic candidate for OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong.
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang.
- Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, Shandong.
- Department of Dermatology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong.
Zitieren
APA
Liu, Z., Liu, R., Yue, H., Liu, P., & Wang, R. (2026). Sinensetin ameliorates osteoarthritis progression by modulating the NF-κB/NLRP3 signaling pathway and suppressing chondrocyte pyroptosis. European Journal of Histochemistry. https://doi.org/10.4081/ejh.2026.4587
Vancouver
Liu Z, Liu R, Yue H, Liu P, Wang R. Sinensetin ameliorates osteoarthritis progression by modulating the NF-κB/NLRP3 signaling pathway and suppressing chondrocyte pyroptosis. European Journal of Histochemistry. 2026. doi:10.4081/ejh.2026.4587
BibTeX
@article{Liu2026,
author = {Liu, Zhendong and Liu, Ruizhou and Yue, Hongwei and Liu, Peilai and Wang, Rui},
title = {Sinensetin ameliorates osteoarthritis progression by modulating the NF-κB/NLRP3 signaling pathway and suppressing chondrocyte pyroptosis},
journal = {European Journal of Histochemistry},
year = {2026},
doi = {10.4081/ejh.2026.4587}
}
EUVIMED